isatuximab
Showing 26 - 37 of 37
Multiple Myeloma, Renal Impairment, Tumors, Plasma Cell Trial in Greece (Isatuximab, Pomalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- +7 more
- Isatuximab
- +5 more
-
Athens, Greece
- +5 more
Mar 17, 2022
Multiple Myeloma Trial in Denmark, Ireland (Isatuximab, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Isatuximab
- +3 more
-
Aarhus, Denmark
- +5 more
Jul 29, 2022
Natural Killer/T-cell Lymphoma, Relapsed Natural Killer/T-cell Lymphoma, Refractory Natural Killer/T-cell Lymphoma Trial in
Recruiting
- Natural Killer/T-cell Lymphoma
- +2 more
- Isatuximab
- Cemiplimab
-
Seoul, Kangnamgu, Korea, Republic ofSamsung Medical Center
Sep 22, 2021
Plasma Cell Myeloma Trial in Czechia, France, United States (Isatuximab)
Completed
- Plasma Cell Myeloma
- Isatuximab
-
Scottsdale, Arizona
- +17 more
Apr 22, 2022
Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Autologous Stem Cell Transplant Trial in Boston (Isatuximab,
Recruiting
- Multiple Myeloma
- +2 more
- Isatuximab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 20, 2021
Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)
Not yet recruiting
- Newly Diagnosed Multiple Myeloma
- Bortezomib
- +4 more
-
Alcalá de Henares, Madrid, Spain
- +67 more
Sep 23, 2022
Multiple Myeloma Trial in France (Isatuximab, ASCT)
Recruiting
- Multiple Myeloma
- Isatuximab
- ASCT
-
AMIENS Cedex 1, France
- +67 more
Mar 28, 2022